Preeclampsia (PE) is a condition that affects women during pregnancy. It is a leading cause of maternal and infant death worldwide and is typically detected in the second trimester or later. Predicting PE at an early stage is one of the most important goals of maternal-fetal medicine. Thus, there is an unmet need for accurate early detection of preeclampsia, ideally at the point-of-care. In a pilot study, microRNA-20a (miR-20a) showed an upregulation in the blood samples of the first trimester of preeclamptic pregnancies when compared to healthy mothers. In this research, a dual capture probe sandwich assay, sensitive to miR-20a, that used surface-enhanced Raman scattering (SERS)-active gold nanoparticles for the signal transduction was developed. The assay was translated to a lateral flow paper fluidic device, for potential low cost and ease of use in low-resource settings. Each paper layer has different pore sizes and features an array of buffers that store nanoparticle conjugates, guide flow, and reduce non-specific binding. Using a handheld Raman reader with a 638 nm excitation laser, reliable SERS detection of miR-20a was shown with resolutions down to 1 nM. Colorimetric detection of these concentrations using the RGB pixels from scanning the test line is also depicted, showing multi-modal detection to potentially enhance specificity for this early epigenetic biomarker.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.